Speakers

Jessica R. Allegretti, Ashwin Ananthakrishnan, Juanita Belton, Charles N. Bernstein, Shubha Bhat, Athos Bousvaros, Diane Bryant, Robert Burakoff, Michael J. Callahan, Adam Cheifetz, Russell D. Cohen, D. Punyanganie DeSilva, Francis Farraye, Joseph D. Feuerstein, Steven N. Fine, Sean Fine, Sonia Friedman, Joel Goldberg, Jess Kaplan, Michael Kappelman, Joshua Korzenik, Mary Kate Lapinel, Alexander Levy, Arpan Mohanty, Alan Moss, Ansu Noronha, Beth-Ann Norton, Randall Pellish, Daniel S. Pratt, Paul A. Rufo, Debjani Sahni, Samir Shah, Scott Snapper, Kathleen Viveiros, Sharmeel Wasan, Joel Weinstock, Rachel Winter, Lori Zimmerman

Jessica R. Allegretti, MD, MPH

Associate Director, Crohn's and Colitis Center
Division of Gastroenterology. Hepatology and Endoscopy
Brigham and Women's Hospital
Assistant Professor of Medicine
Harvard Medical School

Dr. Jessica Allegretti serves as the Associate Director of the Crohn’s and Colitis Center at Brigham and Women’s Hospital, where she leads the Clinical Trials Program. She also serves as the hospital’s Fecal Microbiota Transplantation Program Director.

Back to top

Ashwin Ananthakrishnan, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Director, Crohn’s and Colitis Center
Massachusetts General Hospital

Dr. Ananthakrishnan is an Associate Professor of Medicine and Director of the Crohn's and colitis center at Massachusetts General Hospital. His research focuses on the role of environmental factors in IBD, brain-gut axis, and biomarkers for personalizing IBD care.

Back to top

Juanita Belton, PA-C , MPH, MPAS

Physician Assistant
Boston Medical Center
Crohn's and Colitis Center

Juanita Belton serves as Physician Assistant for the Crohns and Colitis Research Center at Boston Medical Center. She earned her B.S in Biology from Clark Atlanta Univerity in Atlanta, GA., a Masters in Public Health in Maternal and Child Health from the Boston University School of Public Health in Boston, MA, and a Masters in Physician Assistant Studies at the Massachusetts College of Pharmacy and Health Sciences in Manchester, NH. She is an active member of the IBD care team providing medical care, but her passion is also providing education and support to the many patients that she sees. She is currently a participant in the IBD APP and Nurse Preceptorship with the Cleveland Clinic. She was recently chosen as a participant in the Boston University School of Medicine Under-Represented Racial and Ethnics Group Faculty Development Program

Back to top

Charles N. Bernstein, MD

Distinguished Professor of Medicine
Director, University of Manitoba IBD Clinical and Research Centre
Bingham Chair in Gastroenterology
University of Manitoba

Dr. Charles Bernstein, a graduate from the University of Manitoba Faculty of Medicine, and the UCLA Division of Gastroenterology Fellowship Training Program is Distinguished Professor of Medicine, Bingham Chair in Gastroenterology Research; and Director, Inflammatory Bowel Disease (IBD) Clinical and Research Centre at the University of Manitoba. His main research interests are primarily related to IBD; in terms of optimizing management approaches; exploring predictors of clinical outcomes; and disease etiology including related to the gut microbiome. Dr. Bernstein has been a pioneer in Canada in harnessing administrative health data to study chronic immune diseases and in developing a population based database, the University of Manitoba IBD Epidemiology Database, that has both served as a model for the development of other similar databases in other provinces as well as a unique tool to study inflammatory bowel disease. More recently he has been actively involved in exploring the biological and clinical intersection between different chronic immune mediated inflammatory diseases. He has published over 540 peer reviewed articles, 29 book chapters, and is a co-editor of one of the seminal gastrointestinal clinical-pathology textbooks. His H-Index is 86 and has had over 33000 citations. In 2009, he was named the inaugural Bingham Chair in Gastroenterology at the University of Manitoba. In 2012 he was elected into the Royal Society of Canada -Life Sciences Division of the Academy of Science. In 2019 he was awarded the Crohn’s and Colitis Canada Research Leadership Award.

Back to top

Shubha Bhat, PharmD, MS, BCACP

Clinical Pharmacist - Gastroenterology
Crohn's & Colitis Program
Boston Medical Center

Dr. Shubha Bhat is a clinical pharmacist in the gastroenterology clinic at Boston Medical Center. As part of the Crohn’s & Colitis Program, she oversees the medication experience, including education, safety monitoring, and adverse effect management, of patients with inflammatory bowel disease. In addition to clinical practice, Dr. Bhat also partakes in research and teaching. She earned her Doctor of Pharmacy degree from Northeastern University in Boston, Massachusetts and Master’s degree in Clinical Sciences from University of Colorado. She completed PGY1 Pharmacy Residency at Boston Medical Center, PGY2 Ambulatory Care Residency at UIC, and Ambulatory Care Outcomes Fellowship at University of Colorado.

Back to top

Athos Bousvaros, MD, MPH

Course Co-Director
Associate Professor of Pediatrics, Harvard Medical School
Associate Director
IBD Center Associate Chief, Division of Gastroenterology
Boston Children’s Hospital

Athos Bousvaros MD, MPH is Professor of Pediatrics at Harvard Medical School, and Associate Chief at Boston Children's Hospital. He completed his undergraduate degree at Williams College, his medical degree and residency at Duke University, and his gastroenterology fellowship at Children's Hospital Boston, Massachusetts General Hospital and Harvard Medical School. As Associate Director of the Inflammatory Bowel Disease Center at BCH, he spends much of his time treating complex cases of Crohn’s disease and ulcerative colitis referred from across the country. His research interests include identifying the cause of IBD by studying the intestinal microbiome, developing new therapies for IBD, and examining the immune response of IBD patients to immunizations. He has over 100 original and review publications in the medical literature.
He has served as chair of Chapter Medical Advisory Committee of the New England Crohn’s and Colitis Foundation, and national chair of the Pediatric Affairs committee. He has also served as President of the North American Society for Pediatric GI and Nutrition (NASPGHAN). When not busy caring for patients or doing research, he enjoys developing patient education materials for children with chronic illness. These include the medical comics: “Pete Learns All About Crohn’s and Colitis” (with the CCFA), “Amy Goes Gluten Free”, “JD Shapes Up”, and Sophie’s Science Project

Back to top

Diane Bryant, MS, RN, CWOCN

Clinical Nurse Specialist in Wound and Ostomy Care
Brigham and Women's Hospital

Diane Bryant RN, MS.,CWOCN has practiced as a WOC Nurse Clinical Nurse Specialist at Brigham and Women’s Hospital in Boston, Massachusetts for over twenty years Her practice includes patients with new and existing ostomies in the inpatient and outpatient setting. She enjoys educating individuals about ostomy care. Her educational background includes University of Massachusetts Master of Science: Nursing, Emory University Certificate – Enterostomal Therapy Nursing, University of Massachusetts BSN Major: Nursing and Peter Bent Brigham School of Nursing. Currently she serves as a Director for the Wound, Ostomy and Continence Nurses Society.

Back to top

Robert Burakoff, MD, MPH, FACG, AGAF

Professor of Medicine
Weill Cornell Medical College
Vice Chair of Medicine,
Ambulatory Services
Department of Medicine
Weill Cornell Medical College
Professor Emeritus, Harvard Medical School

Robert Burakoff,MD,MPH is Professor of Medicine at Weill Cornell Medical College and has been Vice Chair of Medicine for Ambulatory Operations at Weill Cornell He is Professor Emeritus at Harvard Medical School He was the co founding editor and co editor in chief of the journal Inflammatory Bowel Diseases from 1995-2017 His most recent research interests have been related to the role of whole blood gene array for diagnosis and treatment of IBD


Back to top

Michael J. Callahan, MD

Director, Computed Tomography; Division Chief, Abdominal Imaging; Medical Director, Ultrasound; Staff Radiologist, Department of Radiology
Associate Professor of Radiology, Harvard Medical School

Dr. Callahan is a Pediatric Radiologist at Boston Children's Hospital and an Associate Professor of Radiology at Harvard Medical School. He is the clinical director of Computed Tomography, and the Division Chief of Abdominal imaging at Boston Children's. His interests include general pediatric body imaging and optimizing the use of enteric and intravenous contrast media in infants and children.

Back to top

Adam Cheifetz, MD

Director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.

He is a wellrecognized leader in the treatment of Crohns disease ulcerative colitis and other inflammatory bowel diseases He is involved in multiple research projects relating to IBD and has published over 175 articles and chapters on the subject His research currently focuses on optimizing the use of biologics through the proactive use of drug concentrations and antibodies and he has published extensively in this area Dr Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care

Back to top

Russell D. Cohen, MD, FACG, AGAF

Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
Co-Director, Advanced IBD Fellowship Program
Department of Medicine, Section of Gastroenterology
University of Chicago Medical Center

Russell D. Cohen, MD. FACG, AGAF is a Professor of Medicine in the Department of Medicine, Section of Gastroenterology at the University of Chicago in Illinois. In addition, he is Director of the Inflammatory Bowel Disease Center at the University of Chicago, and the Co-Director of the Advanced IBD Fellowship Program.

Dr. Cohen earned his BS in biological sciences at Cornell University in Ithaca, New York, and his MD with honors at Mount Sinai School of Medicine in New York City. He completed his residency in internal medicine at Beth Israel Hospital/Harvard Medical School in Boston. His fellowship in gastroenterology and nutrition and his senior fellowship in inflammatory bowel diseases were conducted at the University of Chicago. Following his fellowships, Dr. Cohen was a Health Studies Scholar at the University of Chicago.

Research interests of Dr. Cohen includes investigations of both standard and experimental pharmacological therapies, such as novel immunomodulatory agents, as well as studies analyzing quality of life and the economics involved in the diagnosis and treatment of inflammatory bowel disease. He has been Principal Investigator and Co-investigator for more than 185 research projects in his field.

Dr. Cohen is an editor of three medical text books, and has authored or coauthored more than 200 articles, abstracts, reviews, books, book chapters, and audiotapes primarily devoted to Crohn’s disease and ulcerative colitis. His articles on these and related topics are published in prestigious scientific journals such as Gastroenterology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases. He also is a reviewer for multiple journals, including New England Journal of Medicine, Gastroenterology, Gut, and American Journal of Gastroenterology, and is a former Associate Section Editor of the journal Inflammatory Bowel Diseases, He is a member of the American Medical Association, the American College of Gastroenterology, the American College of Physicians, and the American Gastroenterological Association. Dr. Cohen is the recipient of multiple honors and awards, and he is named in Best Doctors in America, America’s Top Gastroenterologists, and Top Doctors in the Chicago Metro Area.

Back to top

D. Punyanganie DeSilva, MBBS, MPH, MRCP(UK)

Assistant Professor of Medicine
Harvard Medical School
Associate Physician
Crohn’s & Colitis Center

Brigham and Women’s Hospital
Dr. De Silva is an Assistant Professor of Medicine at Harvard Medical School and an Associate Physician at the Crohn’s & Colitis Center, Brigham & Women’s Hospital, Boston, MA. She is actively involved in the clinical care of patients with inflammatory bowel disease. Her research focuses on the role of diet and environmental factors in IBD and women’s health in IBD.

Back to top

Francis Farraye, MD, Msc, FACG

Professor of Medicine
Division of Gastroenterology and Hepatology
Director, Inflammatory Bowel Disease Center
Mayo Clinic, Jacksonville, FL
Adjunct Professor of Medicine
Boston University School of Medicine

Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he directs the Inflammatory Bowel Disease Center. A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis and Questions and Answers about Crohn's Disease.
Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn's and Colitis Foundation Membership Committee and a chair of the Chapter Medical Advisory Committee for the Central and North Florida Crohn's and Colitis Foundation. The New England Crohn's and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college.

Back to top

Joseph D. Feuerstein, MD

Associate Clinical Chief, Gastroenterology
Center for Inflammatory Bowel Disease
Associate Professor of Medicine, Harvard Medical School
Beth Israel Deaconess Medical Center

Joseph Feuerstein is a gastroenterologist at Beth Israel Deaconess Medical Center, Boston Massachusetts. He is the Associate Clinical Chief of Gastroenterology, an Associate Professor of Medicine at Harvard Medical School and a physician in the Center for Inflammatory Bowel Disease at Beth Israel Deaconess. He is actively involved in clinical care of patients with inflammatory bowel disease and focuses his research in quality, outcomes, and practice guidelines. He is active on a number of committees for the AGA, CCF, and ACG. He has also authored many of the AGA clinical practice guidelines related to the management of patients with inflammatory bowel disease.

Back to top

Steven N. Fine, MD

Chief of Gastroenterology, MetroWest Medical Center
Medical Director, Boston Endoscopy Center
Assistant Clinical Professor of Medicine, Tufts University School of Medicine

Dr. Fine is the founding physician of Greater Boston Gastroenterology, PC, and has practiced in the MetroWest area for over 28 years. He serves as Chief of the GI Department and Endoscopy Service at MetroWest Medical Center and is the Medical Director of Boston Endoscopy Center in Wellesley.
Dr. Fine is published in a wide range of GI topics, with expertise in GI upper endoscopy, colonoscopy, pill capsule endoscopy, Inflammatory Bowel Disease, and general Gastroenterology. He has been a member of the New England Chapter Medical Advisory Committee for 14 years and served as the Chair for the past two years. Dr. Fine is a leader and advocate for patient protections in Step Therapy (Fail First) legislation

Back to top

Sean Fine, MD, MS

MD, MS
Assistant Professor of Medicine
Warren Alpert Medical School of Brown University
Director, Inflammatory Bowel Disease Cente

My focus is on improving clinical outcomes and quality of care for patients with inflammatory bowel disease (IBD). Specific areas of interest include strategies for positioning of biologic treatments, understanding and managing the hypercoagulable state in IBD, the role of diet and nutrition, and improving outcomes for patients with IBD in high performance sports activity.

Back to top

Sonia Friedman, MD, FACG

Course Co-Director
Associate Professor of Medicine
Harvard Medical School
Associate Physician
Brigham and Women’s Hospital

Sonia Friedman, M.D. is Associate Professor of Medicine at Harvard Medical School and an Associate Physician at Brigham and Women’s Hospital in Boston, Massachusetts. She is the Director of Women’s Health at the Brigham and Women’s Hospital Center for Crohn’s and Colitis.

Back to top

Joel Goldberg, MD, MPH, FACS

Assistant Professor of Surgery
Harvard Medical School
Colon and Rectal Surgery
Brigham and Women's Hospital

Back to top

Jess Kaplan, MD

Pediatric Gastroenterologist
Clinic Director, Pediatric Inflammatory Bowel Disease Program
MassGeneral Hospital for Children
Assistant Professor of Pediatrics
Harvard Medical School

Jess Kaplan is Pediatric Gastroenterologist at MassGeneral Hospital for Children where he is the clinical director of the pediatric inflammatory bowel disease program and an Assistant Professor of Pediatrics at Harvard Medical School.
He is an active investigator in pediatric IBD clinical trials and leads the nutritional therapy program for IBD at MGHfC.

Back to top

Michael Kappelman, MD, MPH

Professor of Pediatrics, University of North Carolina at Chapel Hill

Dr. Kappelman is a pediatric gastroenterologist and health services researcher with a focus on Inflammatory Bowel Disease (IBD). He is a Professor of Pediatrics and an adjunct Professor of Epidemiology at the University of North Carolina at Chapel Hil. In addition to clinical care, he is actively engaged in clinical and comparativeness effectiveness research that uses real-world data to evaluate the risks and benefits of treatments used in everyday clinical practice. His work also focuses on the use of quality improvement strategies to incorporate new knowledge into practice.

Back to top

Joshua Korzenik, MD

Assistant Professor of Medicine
Harvard Medical School
Director, BWH Crohn’s and Colitis Center
Brigham and Women’s Hospital

Back to top

Mary Kate Lapinel, MSN, FNP-C

MGH Crohn’s and Colitis Center

Mary Kate Lapinel is the inflammatory bowel disease nurse practitioner at the Massachusetts General Hospital Crohn’s and Colitis Center.

Back to top

Alexander Levy, MD

Assistant Professor
Tufts University School of Medicine
Gastroenterologist
Tufts Medical Center

Alexander Levy, MD is an Assistant Professor at Tufts University School of Medicine and gastroenterologist with expertise in inflammatory bowel disease (IBD) at Tufts Medical Center. His clinical practice and research focuses on complicated perianal Crohn’s disease, hyperbaric oxygen therapy, and complimentary treatments in IBD.

Back to top

Arpan Mohanty, MBBS

Assistant Professor
Boston University School of Medicine
Gastroenterologist
Boston Medical Center

Dr. Mohanty is a clinical hepatologist at Boston Medical Center and an Assistant Professor of Medicine at Boston University School of Medicine. She completed at residency training in Internal Medicine at University of Pittsburgh Medical Center, fellowship training in Digestive Diseases at Yale University and fellowship training in Advanced/Transplant hepatology at Massachusetts General Hospital.
Dr. Mohanty practices hepatology at Boston Medical Center. Dr. Mohanty’s research focuses on end stage liver disease and its complications for which she has received funding from the American Association for the Study of Liver Diseases and the National Institutes of Health.

Back to top

Alan Moss, MD, FACG, FEBG, AGAF, FRCPI

Professor of Medicine at Boston University School of Medicine
Director of the Crohn’s & Colitis Program
Boston Medical Center

Alan Moss MD is a Professor of Medicine at Boston University School of Medicine, and Director of the Crohn’s & Colitis Program at Boston Medical Center. He has authored over 200 papers, studies, editorials or reviews in the IBD field. His research focuses on biomarkers, microbial therapy, vitamin D and histology in IBD.

Back to top

Ansu Noronha, MD

Assistant Professor
Section of Gastroenterology
Boston Medical Center

Dr. Ansu Noronha MD is a clinician-scientist with an expertise in Inflammatory Bowel Diseases and an Assistant Professor of Medicine at Boston University. She completed her clinical training at Boston Medical Center after receiving her MD from Jefferson Medical College. As a clinician in the Crohn's and Colitis Program at Boston Medical Center, she works as a part of a multi-disciplinary team of gastroenterologists, nutritionists, colorectal surgeons and pharmacists. Current research/clinical interests include the role of the microbiome in GI conditions including IBD, is trained in fecal microbiota transplant and chromoendoscopy.

Back to top

Beth-Ann Norton, MS, RN, ANP-BC

Nursing Program Director
Crohn's and Colitis Center
Brigham and Women’s Hospital

Beth-Ann Norton is a nurse practitioner and the nursing program director at the Brigham and Women’s Crohn’s and Colitis Center. She has cared for patients with IBD for over 21 years. She has been a sub-investigator in numerous clinical trials and is published in and a frequent invited speaker on the topics of IBD.

Back to top

Randall Pellish, MD

Director, Inflammatory Bowel Disease Center
Division of Gastroenterology
Lahey Hospital & Medical Center

Dr. Randall Pellish is a graduate of the University of Massachusetts Medical School, and trained at Brown University Medical School/Rhode Island Hospital. He is the Director of the Lahey Inflammatory Bowel Disease Center at the Lahey Hospital and Medical Center in Burlington, MA, and an Assistant Professor of Medicine at Tufts Medical School.

Back to top

Daniel S. Pratt, MD, FAASLD

Clinical Director, Liver Transplantation
Director, Autoimmune & Cholestatic Liver Center
Massachusetts General Hospital

Back to top

Paul A. Rufo, MD, MMSc

Program Director, Harvard Medical School Fellowship in Pediatric Gastroenterology
Division of Gastroenterology
Boston Children's Hospital
Assistant Professor of Pediatrics
Harvard Medical School

Dr. Paul Rufo directs the GI Fellowship at Boston Children's Hospital where he is a senior investigator in the Center for Inflammatory Bowel Disease. His research is focused on medical education, biomarker development, and quality improvement initiatives related to the management of IBD in children and young adults.

Back to top

Debjani Sahni, MBBS

Assistant Professor of Dermatology
Boston University School of Medicine
Dermatologist
Boston Medical Center

Dr Sahni is assistant professor in the Department of Dermatology at Boston University Medical Center where she serves as the director of the multi-disciplinary Cutaneous Oncology Program. She specializes in the care of cutaneous oncology patients including cutaneous lymphomas and the medical management of melanoma and high-risk non-melanoma skin cancers. Dr Sahni is the director of the Cutaneous Oncology Fellowship and she is also director of the International Program in Dermatology (IGPD). A unique and highly respected program, the IGPD was first established in 1988 and offers international postgraduate doctors the opportunity to train in dermatology, utilizing state-of-the-art facilities and therapies available in the US. Dr Sahni’s clinical research interests focus on the epidemiology and treatment of skin cancers.

Back to top

Samir Shah, MD, FACG, FASGE, AGAF

Clinical Professor of Medicine
Alpert Medical School of Brown University
Chief of Gastroenterology, The Miriam Hospital
Gastroenterology Associates, Inc.

Samir A. Shah, MD, FACG, is a Clinical Professor of Medicine at the Alpert Medical School of Brown University, Chief of Gastroenterology at the Miriam Hospital and a partner with Gastroenterology Associates, Inc in Providence, RI. Dr. Shah earned his BA in Biochemistry magna cum laude at Brown, and his MD at Harvard Medical School in Boston, MA. He did a residency in Internal Medicine at the Harvard-affiliated Beth Israel Deaconess Medical Center and stayed on for fellowship in Gastroenterology, where he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians and spent two years in the laboratory studying murine models of Inflammatory Bowel Disease. Dr. Shah is the recipient of Brown University's Teaching Recognition Award, The Dean's Teaching Excellence Certificate, Brown University's Excellence in Teaching Award for Clinical Faculty, the Beckwith Family Award for Outstanding Teaching, the ACG's Freshman Governor's Award, and the William D. Carey Award. The New England Chapter of the Crohn's and Colitis Foundation of America named him Humanitarian of the Year for 2009. Rhode Island Monthly magazine consistently names him among the Top Doctors in Rhode Island. He currently serves as co-chair of the CCFA Membership Committee, Physician Lead for his groups' participation in IBD QORUS, President of the Digestive Diseases National Coalition (DDNC), co-chair of ACG's online IBD Circle, and on the ACG's Board of Trustees as Vice President. He has participated in several multi-center clinical trials of cutting-edge therapies for IBD and was co-principal investigator for OSCCAR (Ocean State Crohn's and Colitis Area Registry).

Back to top

Scott Snapper, MD, PhD

Chief, Division of Gastroenterology, Hepatology, and Nutrition;
Wolpow Family Chair and Director, Inflammatory Bowel Disease Center (Boston Children's Hospital)
Physician, Crohn’s and Colitis Center, Division of Gastroenterology (Brigham and Women’s Hospital)
Egan Family Foundation Professor of Pediatrics in the Field of Transitional Medicine & Professor of Medicine (Harvard Medical School)

Dr. Snapper is a physician-scientist with a passion both for patient care as well as research focusing on understanding the role of the immune system in inflammatory bowel diseases and immunodeficiencies. Dr. Snapper is the Wolpow Family Chair and Director of the Center for Inflammatory Bowel Disease at Boston Children’s Hospital. In January 2020, Dr. Snapper became the Chief of the Division of Gastroenterology, Hepatology and Nutrition. In addition, Dr. Snapper is a Physician within the Crohn’s and Colitis Center at Brigham & Women’s Hospital where he maintains a joint clinical appointment. Dr. Snapper is Professor of Medicine and the Egan Family Foundation Professor of Pediatrics at Harvard Medical School.

For the last two decades, his laboratory has been investigating how the “adaptive” and “innate” arms of the immune system maintain health in the intestine. In particular his laboratory is trying to understand how a defective immune system can contribute simultaneously to both immunodeficiency and intestinal inflammation with some focus on human immunodeficiencies. His laboratory has made numerous key discoveries related to patients with the Wiskott-Aldrich syndrome and, more recently, with those containing IL-10 receptor deficiency – both immune deficiencies that are associated with the combination of severe immune abnormalities and intestinal inflammation.

Currently, his laboratory is characterizing new genes that are associated with IBD and testing novel treatment strategies to manipulate immunoregulatory circuits in mice and man for IBD disease prevention and therapy. He and his team have developed novel mouse strains that permit them to study the role of human immune cells in mice. This novel approach is laying a foundation for these models to become important pre-clinical tools that will allow development and testing of novel therapeutic strategies that promote human immune homeostasis. A major goal of Dr. Snapper’s recent activities is to identify the causes that lead to very early onset inflammatory bowel disease (VEO-IBD) and to develop novel personalized therapeutic options based on these findings. Together with Dr. A. Muise in Toronto, and Dr. C. Klein in Munich, Dr. Snapper leads an international consortium (VEOIBD Consortium; www.veoibd.org) focused on this effort.

Dr. Snapper has authored over 175 original articles and book chapters, and receives multiple grants from the NIH, the Crohn’s and Colitis Foundation, the Helmsley Charitable Trust, the Rainin Foundation, and from major pharmaceutical companies. Dr. Snapper is on the editorial board of several journals, is a member of numerous scientific advisory boards of major pharmaceutical and biotechnology companies, serves as a permanent member of the Gastrointestinal Mucosal Pathobiology Study Section of the NIH, is on the scientific advisory board of the Rainin Foundation, and is the recent chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation.

Back to top

Kathleen Viveiros, MD

Instructor, Harvard Medical School
Gastroenterology, Hepatology and Endoscopy
Brigham and Women's Hospital

Kathleen Viveiros, MD is one of the Transplant Hepatologists in the GI/Hepatology Division at Brigham and Women’s Hospital and Instructor at Harvard Medical School. Her clinical interests include Non-alcoholic Fatty Liver Disease, Autoimmune Liver Disease, Primary Biliary Cholangitis, Alcohol-related liver disease and Cirrhosis management.

Back to top

Sharmeel Wasan, MD, FACG

Course Co-Director
Assistant Professor of Medicine, Boston University
Fellowship Program Director, Section of Gastroenterology
Boston Medical Center

Sharmeel K Wasan, MD, FACG is a clinician-educator with an expertise in Inflammatory Bowel Diseases (IBD) and an Assistant Professor of Medicine at Boston University. She completed her clinical training at Boston Medical Center, the Brigham and Women’s Hospital, and the University of Maryland. She received her BS in Biological Sciences and BA in Anthropology from Stanford University in Palo Alto, CA and received her MD from Albert Einstein College of Medicine in New York. As the Fellowship Program Director for the Section of Gastroenterology and Hepatology at Boston Medical Center, she is actively involved in the training of fellows, residents, and medical students. Her current clinical and research interests include vaccination strategies, health care maintenance in patients with IBD, and educational strategies in endoscopy training and has received research and educational grants from BU and from industry supported funding.

Back to top

Joel Weinstock, MD

Professor at Tufts University and Tufts Medical Center
Director of Crohn’s and Colitis Center at Tufts Medical Center

Dr. Weinstock is Division Chief Emeritus in the Division of Gastroenterology/Hepatology at Tufts Medical Center. He is noted for his publications related to the study of mechanisms of immune regulation at gut mucosal surfaces as it relates to IBD. He is a pioneer in concepts pertaining to the cause of IBD and of the “hygiene hypothesis”. He also is noted for his work in neuroimmunology showing how nerves and various neuropeptides effect immune response in inflammation.

Back to top

Rachel Winter, MD, MPH

Instructor in Medicine, Harvard Medical School
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital

Dr. Winter is an Instructor in Medicine at Harvard Medical School and an Associate Physician at the Crohn’s & Colitis Center, Brigham & Women’s Hospital. Her research focuses on women’s health in IBD. She is also co-director of the multidisciplinary psychosocial program at the Brigham and Women's IBD Center.

Back to top

Lori Zimmerman, MD

Instructor in Pediatrics, Harvard Medical School
Attending Physician
Division of Gastroenterology and Nutrition
Boston Children’s Hospital

Back to top